-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Upgrades Vera Therapeutics to Outperform, Announces $88 Price Target

Benzinga·03/11/2026 11:45:42
Listen to the news
Wolfe Research analyst Andy Chen upgrades Vera Therapeutics (NASDAQ:VERA) from Peer Perform to Outperform and announces $88 price target.